Grant Pickering was Appointed as Chief Executive Officer at SutroVax

Date of management change: March 15, 2013 

What Happened?

South San Francisco, CA-based SutroVax Appointed Grant Pickering as Chief Executive Officer

 

About the Company

SutroVax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases. SutroVax`s lead product candidate is a pneumococcal conjugate vaccine (PCV) that is designed to prevent invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae. SutroVax`s broad-spectrum PCV is designed to provide expanded protection against circulating strains of pneumococcus and has the potential to replace the current vaccines used in infants and adults. The current mainstay vaccine only covers approximately 40% of the circulating strains causing IPD yet generates $6B in annual sales. SutroVax has generated positive pre-clinical proof-of-concept with its significantly broader-spectrum PCV compared head-to-head to current vaccines using well accepted immunological endpoints. In addition to its lead PCV product candidate, the Company also has a promising early-stage pipeline addressing other important disease areas. SutroVax`s conjugate vaccines are developed utilizing the Company`s exclusive rights to Sutro Biopharma`s Xpress CF Platform, a cell-free protein synthesis technology. SutroVax closed its $85M Series C round in May of 2018 and is financed by a world-class syndicate of private equity, venture capital and corporate venture investors with over $170M in capital raised since 2015.

 

About the Person

Pickering is the enterprising, judicious leader and entrepreneur who is extremely adept at identifying and crafting a compelling vision for novel technology to generate significant value for emerging businesses. Leading role in the development and commercialization of multiple therapeutic products, including Provenge. Track record of operational success in biopharmaceutical commercialization, clinical development, project management, fundraising and corporate development. Strong ties throughout the biotech, pharmaceutical and investment community.  

 

Info Source

Press Release

 
 

Other IT executives who recently changed jobs as well: Vis Vinesh, Hinkle Richard, Ziebarth David, Otto Nathan, Beck Renee, Fatum Russ, Tebedo Tara, Hellman Chris, Benson John, Fallucco Thomas, Gradman Steve

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.